FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 328:847-854 March 25, 1993 Number 12 Next

	Full Text Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

ABSTRACT

Background and Methods The nerve growth factor receptor is expressed in some neuroblastomas, in which its primary component is encoded by the TRK proto-oncogene. To determine the relation of the expression of TRK messenger RNA in neuroblastomas to other clinical and laboratory variables, we studied frozen tumor samples from 77 patients. In addition, we tested two primary neuroblastomas that expressed TRK for responsiveness to nerve growth factor.

Results TRK expression strongly correlated with favorable tumor stage (I, II, and IVS vs. III and IV), younger age (<1 year vs. 1 year), normal N-myc copy number, and low level of N-myc expression. N-myc amplification (indicated by a high copy number) correlated with advanced tumor stage, older age, an adrenal site of the primary tumor, low level of expression of TRK, and high level of expression of N-myc. Analysis of five-year cumulative-survival rates demonstrated an association of a very favorable outcome with a high level of TRK expression (86 percent vs. 14 percent) and with normal N-myc copy number (84 percent vs. 0 percent). Univariate analysis showed that these two variables were the most powerful predictors of outcome (chi-square = 51.30, P<0.001; and chi-square = 93.61, P<0.001, respectively). TRK expression still had significant prognostic value when the analysis was restricted to tumors without N-myc amplification. In primary cultures of neuroblastoma cells expressing TRK, exposure to nerve growth factor induced early gene expression and neurite outgrowth, but deprivation of nerve growth factor led to neuronal cell death.

Conclusions A high level of expression of the TRK proto-oncogene in a neuroblastoma is strongly predictive of a favorable outcome. A tumor with a functional nerve growth factor receptor may be dependent on the neurotrophin nerve growth factor for survival and may regress in its absence, allowing a new approach to the treatment of certain patients with neuroblastoma. .

Source Information

From the Department of Pediatrics, Washington University School of Medicine, St. Louis (A.N., M.A.-N., N.J.S., C.G.A., G.M.B.), the Pediatric Oncology Group Statistical Office, Gainesville, Fla. (A.B.C.), and the Pediatric Oncology Group, St. Louis (G.M.B., A.B.C.).

Address reprint requests to Dr. Brodeur at the Department of Pediatrics, Washington University School of Medicine, 1 Children's Place, St. Louis, MO 63110.

Full Text of this Article

This article has been cited by other articles:

• Thiele, C. J., Li, Z., McKee, A. E. (2009). On Trk--The TrkB Signal Transduction Pathway Is an Increasingly Important Target in Cancer Biology. Clin. Cancer Res. 15: 5962-5967 [Abstract] [Full Text]  
• Vasudevan, S. A., Shang, X., Chang, S., Ge, N., Diaz-Miron, J. L., Russell, H. V., Hicks, M. J., Ludwig, A. D., Wesson, C. L., Burlingame, S. M., Kim, E. S., Khan, J., Yang, J., Nuchtern, J. G. (2009). Neuroblastoma-derived secretory protein is a novel secreted factor overexpressed in neuroblastoma. Molecular Cancer Therapeutics 8: 2478-2489 [Abstract] [Full Text]  
• Brodeur, G. M., Minturn, J. E., Ho, R., Simpson, A. M., Iyer, R., Varela, C. R., Light, J. E., Kolla, V., Evans, A. E. (2009). Trk Receptor Expression and Inhibition in Neuroblastomas. Clin. Cancer Res. 15: 3244-3250 [Abstract] [Full Text]  
• Li, Z., Beutel, G., Rhein, M., Meyer, J., Koenecke, C., Neumann, T., Yang, M., Krauter, J., von Neuhoff, N., Heuser, M., Diedrich, H., Gohring, G., Wilkens, L., Schlegelberger, B., Ganser, A., Baum, C. (2009). High-affinity neurotrophin receptors and ligands promote leukemogenesis. Blood 113: 2028-2037 [Abstract] [Full Text]  
• Caporali, A., Emanueli, C. (2009). Cardiovascular Actions of Neurotrophins. Physiol. Rev. 89: 279-308 [Abstract] [Full Text]  
• Yagyu, S., Gotoh, T., Iehara, T., Miyachi, M., Katsumi, Y., Tsubai-Shimizu, S., Kikuchi, K., Tamura, S., Tsuchiya, K., Imamura, T., Misawa-Furihata, A., Sugimoto, T., Sawada, T., Hosoi, H. (2008). Circulating Methylated-DCR2 Gene in Serum as an Indicator of Prognosis and Therapeutic Efficacy in Patients with MYCN Nonamplified Neuroblastoma. Clin. Cancer Res. 14: 7011-7019 [Abstract] [Full Text]  
• Oberthuer, A., Kaderali, L., Kahlert, Y., Hero, B., Westermann, F., Berthold, F., Brors, B., Eils, R., Fischer, M. (2008). Subclassification and Individual Survival Time Prediction from Gene Expression Data of Neuroblastoma Patients by Using CASPAR. Clin. Cancer Res. 14: 6590-6601 [Abstract] [Full Text]  
• Hsu, W.-M., Lee, H., Juan, H.-F., Shih, Y.-Y., Wang, B.-J., Pan, C.-Y., Jeng, Y.-M., Chang, H.-H., Lu, M.-Y., Lin, K.-H., Lai, H.-S., Chen, W.-J., Tsay, Y.-G., Liao, Y.-F., Hsieh, F.-J. (2008). Identification of GRP75 as an Independent Favorable Prognostic Marker of Neuroblastoma by a Proteomics Analysis. Clin. Cancer Res. 14: 6237-6245 [Abstract] [Full Text]  
• Munirajan, A. K., Ando, K., Mukai, A., Takahashi, M., Suenaga, Y., Ohira, M., Koda, T., Hirota, T., Ozaki, T., Nakagawara, A. (2008). KIF1B{beta} Functions as a Haploinsufficient Tumor Suppressor Gene Mapped to Chromosome 1p36.2 by Inducing Apoptotic Cell Death. J. Biol. Chem. 283: 24426-24434 [Abstract] [Full Text]  
• Molenaar, J. J., Ebus, M. E., Koster, J., Sluis, P. v., van Noesel, C. J.M., Versteeg, R., Caron, H. N. (2008). Cyclin D1 and CDK4 Activity Contribute to the Undifferentiated Phenotype in Neuroblastoma. Cancer Res. 68: 2599-2609 [Abstract] [Full Text]  
• Ikegaki, N., Gotoh, T., Kung, B., Riceberg, J. S., Kim, D. Y., Zhao, H., Rappaport, E. F., Hicks, S. L., Seeger, R. C., Tang, X. X. (2007). De novo Identification of MIZ-1 (ZBTB17) Encoding a MYC-Interacting Zinc-Finger Protein as a New Favorable Neuroblastoma Gene. Clin. Cancer Res. 13: 6001-6009 [Abstract] [Full Text]  
• Zhang, J., Chen, X. (2007). {Delta}Np73 Modulates Nerve Growth Factor-Mediated Neuronal Differentiation through Repression of TrkA. Mol. Cell. Biol. 27: 3868-3880 [Abstract] [Full Text]  
• Schramm, A., Vandesompele, J., Schulte, J. H., Dreesmann, S., Kaderali, L., Brors, B., Eils, R., Speleman, F., Eggert, A. (2007). Translating Expression Profiling into a Clinically Feasible Test to Predict Neuroblastoma Outcome. Clin. Cancer Res. 13: 1459-1465 [Abstract] [Full Text]  
• Oberthuer, A., Berthold, F., Warnat, P., Hero, B., Kahlert, Y., Spitz, R., Ernestus, K., Konig, R., Haas, S., Eils, R., Schwab, M., Brors, B., Westermann, F., Fischer, M. (2006). Customized Oligonucleotide Microarray Gene Expression-Based Classification of Neuroblastoma Patients Outperforms Current Clinical Risk Stratification. JCO 24: 5070-5078 [Abstract] [Full Text]  
• Asgharzadeh, S., Pique-Regi, R., Sposto, R., Wang, H., Yang, Y., Shimada, H., Matthay, K., Buckley, J., Ortega, A., Seeger, R. C. (2006). Prognostic Significance of Gene Expression Profiles of Metastatic Neuroblastomas Lacking MYCN Gene Amplification.. JNCI J Natl Cancer Inst 98: 1193-1203 [Abstract] [Full Text]  
• Nakamura, K., Martin, K. C., Jackson, J. K., Beppu, K., Woo, C.-W., Thiele, C. J. (2006). Brain-Derived Neurotrophic Factor Activation of TrkB Induces Vascular Endothelial Growth Factor Expression via Hypoxia-Inducible Factor-1{alpha} in Neuroblastoma Cells.. Cancer Res. 66: 4249-4255 [Abstract] [Full Text]  
• Haber, M., Smith, J., Bordow, S. B., Flemming, C., Cohn, S. L., London, W. B., Marshall, G. M., Norris, M. D. (2006). Association of High-Level MRP1 Expression With Poor Clinical Outcome in a Large Prospective Study of Primary Neuroblastoma. JCO 24: 1546-1553 [Abstract] [Full Text]  
• Tang, X. X., Zhao, H., Kung, B., Kim, D. Y., Hicks, S. L., Cohn, S. L., Cheung, N.-K., Seeger, R. C., Evans, A. E., Ikegaki, N. (2006). The MYCN Enigma: Significance of MYCN Expression in Neuroblastoma.. Cancer Res. 66: 2826-2833 [Abstract] [Full Text]  
• Ho, R., Minturn, J. E., Hishiki, T., Zhao, H., Wang, Q., Cnaan, A., Maris, J., Evans, A. E., Brodeur, G. M. (2005). Proliferation of Human Neuroblastomas Mediated by the Epidermal Growth Factor Receptor. Cancer Res. 65: 9868-9875 [Abstract] [Full Text]  
• George, R. E., London, W. B., Cohn, S. L., Maris, J. M., Kretschmar, C., Diller, L., Brodeur, G. M., Castleberry, R. P., Look, A. T. (2005). Hyperdiploidy Plus Nonamplified MYCN Confers a Favorable Prognosis in Children 12 to 18 Months Old With Disseminated Neuroblastoma: A Pediatric Oncology Group Study. JCO 23: 6466-6473 [Abstract] [Full Text]  
• Lavoie, J.-F., LeSauteur, L., Kohn, J., Wong, J., Furtoss, O., Thiele, C. J., Miller, F. D., Kaplan, D. R. (2005). TrkA Induces Apoptosis of Neuroblastoma Cells and Does So via a p53-dependent Mechanism. J. Biol. Chem. 280: 29199-29207 [Abstract] [Full Text]  
• Parran, D. K., Barker, A., Ehrich, M. (2005). Effects of Thimerosal on NGF Signal Transduction and Cell Death in Neuroblastoma Cells. Toxicol Sci 86: 132-140 [Abstract] [Full Text]  
• Osajima-Hakomori, Y., Miyake, I., Ohira, M., Nakagawara, A., Nakagawa, A., Sakai, R. (2005). Biological Role of Anaplastic Lymphoma Kinase in Neuroblastoma. Am. J. Pathol. 167: 213-222 [Abstract] [Full Text]  
• Aoyama, M., Ozaki, T., Inuzuka, H., Tomotsune, D., Hirato, J., Okamoto, Y., Tokita, H., Ohira, M., Nakagawara, A. (2005). LMO3 Interacts with Neuronal Transcription Factor, HEN2, and Acts as an Oncogene in Neuroblastoma. Cancer Res. 65: 4587-4597 [Abstract] [Full Text]  
• Terui, E., Matsunaga, T., Yoshida, H., Kouchi, K., Kuroda, H., Hishiki, T., Saito, T., Yamada, S.-i., Shirasawa, H., Ohnuma, N. (2005). Shc Family Expression in Neuroblastoma: High Expression of shcC Is Associated with a Poor Prognosis in Advanced Neuroblastoma. Clin. Cancer Res. 11: 3280-3287 [Abstract] [Full Text]  
• Sitek, B., Apostolov, O., Stuhler, K., Pfeiffer, K., Meyer, H. E., Eggert, A., Schramm, A. (2005). Identification of Dynamic Proteome Changes Upon Ligand Activation of Trk-Receptors Using Two-dimensional Fluorescence Difference Gel Electrophoresis and Mass Spectrometry. Mol. Cell. Proteomics 4: 291-299 [Abstract] [Full Text]  
• Hsu, W. M., Hsieh, F. J., Jeng, Y. M., Kuo, M. L., Chen, C. N., Lai, D. M., Hsieh, L. J., Wang, B. T., Tsao, P. N., Lee, H., Lin, M. T., Lai, H. S., Chen, W. J. (2005). Calreticulin expression in neuroblastoma--a novel independent prognostic factor. Ann Oncol 16: 314-321 [Abstract] [Full Text]  
• Abe, M., Ohira, M., Kaneda, A., Yagi, Y., Yamamoto, S., Kitano, Y., Takato, T., Nakagawara, A., Ushijima, T. (2005). CpG Island Methylator Phenotype Is a Strong Determinant of Poor Prognosis in Neuroblastomas. Cancer Res. 65: 828-834 [Abstract] [Full Text]  
• Hienonen, T, Sammalkorpi, H, Isohanni, P, Versteeg, R, Karikoski, R, Aaltonen, L A (2005). A 17p11.2 germline deletion in a patient with Smith-Magenis syndrome and neuroblastoma. J. Med. Genet. 42: e3-e3 [Full Text]  
• Uccini, S., Mannarino, O., McDowell, H. P., Pauser, U., Vitali, R., Natali, P. G., Altavista, P., Andreano, T., Coco, S., Boldrini, R., Bosco, S., Clerico, A., Cozzi, D., Donfrancesco, A., Inserra, A., Kokai, G., Losty, P. D., Nicotra, M. R., Raschella, G., Tonini, G. P., Dominici, C. (2005). Clinical and Molecular Evidence for c-kit Receptor as a Therapeutic Target in Neuroblastic Tumors. Clin. Cancer Res. 11: 380-389 [Abstract] [Full Text]  
• Roberts, S. S., Mori, M., Pattee, P., Lapidus, J., Mathews, R., O'Malley, J. P., Hsieh, Y. C., Turner, M. A., Wang, Z., Tian, Q., Rodland, M. J., Reynolds, C. P., Seeger, R. C., Nagalla, S. R. (2004). GABAergic System Gene Expression Predicts Clinical Outcome in Patients With Neuroblastoma. JCO 22: 4127-4134 [Abstract] [Full Text]  
• Wei, J. S., Greer, B. T., Westermann, F., Steinberg, S. M., Son, C.-G., Chen, Q.-R., Whiteford, C. C., Bilke, S., Krasnoselsky, A. L., Cenacchi, N., Catchpoole, D., Berthold, F., Schwab, M., Khan, J. (2004). Prediction of Clinical Outcome Using Gene Expression Profiling and Artificial Neural Networks for Patients with Neuroblastoma. Cancer Res. 64: 6883-6891 [Abstract] [Full Text]  
• Tang, X. X., Robinson, M. E., Riceberg, J. S., Kim, D. Y., Kung, B., Titus, T. B., Hayashi, S., Flake, A. W., Carpentieri, D., Ikegaki, N. (2004). Favorable Neuroblastoma Genes and Molecular Therapeutics of Neuroblastoma. Clin. Cancer Res. 10: 5837-5844 [Abstract] [Full Text]  
• Hansford, L. M., Thomas, W. D., Keating, J. M., Burkhart, C. A., Peaston, A. E., Norris, M. D., Haber, M., Armati, P. J., Weiss, W. A., Marshall, G. M. (2004). Mechanisms of embryonal tumor initiation: Distinct roles for MycN expression and MYCN amplification. Proc. Natl. Acad. Sci. USA 101: 12664-12669 [Abstract] [Full Text]  
• Irshad, S., Pedley, R. B., Anderson, J., Latchman, D. S., Budhram-Mahadeo, V. (2004). The Brn-3b Transcription Factor Regulates the Growth, Behavior, and Invasiveness of Human Neuroblastoma Cells in Vitro and in Vivo. J. Biol. Chem. 279: 21617-21627 [Abstract] [Full Text]  
• Liu, Y., Encinas, M., Comella, J. X., Aldea, M., Gallego, C. (2004). Basic Helix-Loop-Helix Proteins Bind to TrkB and p21Cip1 Promoters Linking Differentiation and Cell Cycle Arrest in Neuroblastoma Cells. Mol. Cell. Biol. 24: 2662-2672 [Abstract] [Full Text]  
• Weber, A., Huesken, C., Bergmann, E., Kiess, W., Christiansen, N. M., Christiansen, H. (2003). Coexpression of Insulin Receptor-Related Receptor and Insulin-Like Growth Factor 1 Receptor Correlates with Enhanced Apoptosis and Dedifferentiation in Human Neuroblastomas. Clin. Cancer Res. 9: 5683-5692 [Abstract] [Full Text]  
• Tokiwa, K., Fumino, S., Ono, S., Iwai, N. (2003). Results of Retroperitoneal Lymphadenectomy in the Treatment of Abdominal Neuroblastoma. Arch Surg 138: 711-715 [Abstract] [Full Text]  
• Weinstein, J. L., Katzenstein, H. M., Cohn, S. L. (2003). Advances in the Diagnosis and Treatment of Neuroblastoma. The Oncologist 8: 278-292 [Abstract] [Full Text]  
• Saito-Ohara, F., Imoto, I., Inoue, J., Hosoi, H., Nakagawara, A., Sugimoto, T., Inazawa, J. (2003). PPM1D Is a Potential Target for 17q Gain in Neuroblastoma. Cancer Res. 63: 1876-1883 [Abstract] [Full Text]  
• Chlenski, A., Liu, S., Crawford, S. E., Volpert, O. V., DeVries, G. H., Evangelista, A., Yang, Q., Salwen, H. R., Farrer, R., Bray, J., Cohn, S. L. (2002). SPARC Is a Key Schwannian-derived Inhibitor Controlling Neuroblastoma Tumor Angiogenesis. Cancer Res. 62: 7357-7363 [Abstract] [Full Text]  
• Ho, R., Eggert, A., Hishiki, T., Minturn, J. E., Ikegaki, N., Foster, P., Camoratto, A. M., Evans, A. E., Brodeur, G. M. (2002). Resistance to Chemotherapy Mediated by TrkB in Neuroblastomas. Cancer Res. 62: 6462-6466 [Abstract] [Full Text]  
• Jaboin, J., Kim, C. J., Kaplan, D. R., Thiele, C. J. (2002). Brain-derived Neurotrophic Factor Activation of TrkB Protects Neuroblastoma Cells from Chemotherapy-induced Apoptosis via Phosphatidylinositol 3'-Kinase Pathway. Cancer Res. 62: 6756-6763 [Abstract] [Full Text]  
• Kitanaka, C., Kato, K., Ijiri, R., Sakurada, K., Tomiyama, A., Noguchi, K., Nagashima, Y., Nakagawara, A., Momoi, T., Toyoda, Y., Kigasawa, H., Nishi, T., Shirouzu, M., Yokoyama, S., Tanaka, Y., Kuchino, Y. (2002). Increased Ras Expression and Caspase-Independent Neuroblastoma Cell Death: Possible Mechanism of Spontaneous Neuroblastoma Regression. JNCI J Natl Cancer Inst 94: 358-368 [Abstract] [Full Text]  
• Eggert, A., Grotzer, M. A., Ikegaki, N., Liu, X.-g., Evans, A. E., Brodeur, G. M. (2002). Expression of the Neurotrophin Receptor TrkA Down-Regulates Expression and Function of Angiogenic Stimulators in SH-SY5Y Neuroblastoma Cells. Cancer Res. 62: 1802-1808 [Abstract] [Full Text]  
• Bown, N (2001). Neuroblastoma tumour genetics: clinical and biological aspects. J. Clin. Pathol. 54: 897-910 [Abstract] [Full Text]  
• Eggert, A., Grotzer, M. A., Ikegaki, N., Zhao, H., Cnaan, A., Brodeur, G. M., Evans, A. E. (2001). Expression of the Neurotrophin Receptor TrkB Is Associated With Unfavorable Outcome in Wilms' Tumor. JCO 19: 689-696 [Abstract] [Full Text]  
• Edsjö, A., Hallberg, B., Fagerström, S., Larsson, C., Axelson, H., Påhlman, S. (2001). Differences in Early and Late Responses between Neurotrophin-stimulated trkA- and trkC-transfected SH-SY5Y Neuroblastoma Cells. Cell Growth Differ. 12: 39-50 [Abstract] [Full Text]  
• Matthay, K. K. (2000). MYCN Expression in Neuroblastoma: A Mixed Message?. JCO 18: 3591-3594 [Full Text]  
• Cohn, S. L., London, W. B., Huang, D., Katzenstein, H. M., Salwen, H. R., Reinhart, T., Madafiglio, J., Marshall, G. M., Norris, M. D., Haber, M. (2000). MYCN Expression Is Not Prognostic of Adverse Outcome in Advanced-Stage Neuroblastoma With Nonamplified MYCN. JCO 18: 3604-3613 [Abstract] [Full Text]  
• Huang, D., Rutkowski, J. L., Brodeur, G. M., Chou, P. M., Kwiatkowski, J. L., Babbo, A., Cohn, S. L. (2000). Schwann Cell-conditioned Medium Inhibits Angiogenesis. Cancer Res. 60: 5966-5971 [Abstract] [Full Text]  
• Matsunaga, T., Shirasawa, H., Hishiki, T., Yoshida, H., Kouchi, K., Ohtsuka, Y., Kawamura, K., Etoh, T., Ohnuma, N. (2000). Enhanced Expression of N-myc Messenger RNA in Neuroblastomas Found by Mass Screening. Clin. Cancer Res. 6: 3199-3204 [Abstract] [Full Text]  
• Eggert, A., Ikegaki, N., Kwiatkowski, J., Zhao, H., Brodeur, G. M., Himelstein, B. P. (2000). High-Level Expression of Angiogenic Factors Is Associated with Advanced Tumor Stage in Human Neuroblastomas. Clin. Cancer Res. 6: 1900-1908 [Abstract] [Full Text]  
• Sarkar, A. K., Nuchtern, J. G. (2000). Lysis of MYCN-amplified Neuroblastoma Cells by MYCN Peptide-specific Cytotoxic T Lymphocytes. Cancer Res. 60: 1908-1913 [Abstract] [Full Text]  
• Grotzer, M. A., Janss, A. J., Fung, K.-M., Biegel, J. A., Sutton, L. N., Rorke, L. B., Zhao, H., Cnaan, A., Phillips, P. C., Lee, V. M.-Y., Trojanowski, J. Q. (2000). TrkC Expression Predicts Good Clinical Outcome in Primitive Neuroectodermal Brain Tumors. JCO 18: 1027-1027 [Abstract] [Full Text]  
• Evans, A. E., Kisselbach, K. D., Yamashiro, D. J., Ikegaki, N., Camoratto, A. M., Dionne, C. A., Brodeur, G. M. (1999). Antitumor Activity of CEP-751 (KT-6587) on Human Neuroblastoma and Medulloblastoma Xenografts. Clin. Cancer Res. 5: 3594-3602 [Abstract] [Full Text]  
• Packer, R. J., Cogen, P., Vezina, G., Rorke, L. B. (1999). Medulloblastoma: Clinical and biologic aspects. Neuro Oncol Duke 1: 232-250 [Abstract]  
• Maris, J. M., Matthay, K. K. (1999). Molecular Biology of Neuroblastoma. JCO 17: 2264-2264 [Abstract] [Full Text]  
• Cohn, S. L. (1999). Diagnosis and Classification of the Small Round-Cell Tumors of Childhood. Am. J. Pathol. 155: 11-15 [Full Text]  
• Bown, N., Cotterill, S., Lastowska, M., O'Neill, S., Pearson, A. D.J., Plantaz, D., Meddeb, M., Danglot, G., Brinkschmidt, C., Christiansen, H., Laureys, G., Speleman, F., Nicholson, J., Bernheim, A., Betts, D. R., Vandesompele, J., Van Roy, N. (1999). Gain of Chromosome Arm 17q and Adverse Outcome in Patients with Neuroblastoma. NEJM 340: 1954-1961 [Abstract] [Full Text]  
• Middlemas, D. S., Kihl, B. K., Zhou, J., Zhu, X. (1999). Brain-derived Neurotrophic Factor Promotes Survival and Chemoprotection of Human Neuroblastoma Cells. J. Biol. Chem. 274: 16451-16460 [Abstract] [Full Text]  
• Tang, X. X., Evans, A. E., Zhao, H., Cnaan, A., London, W., Cohn, S. L., Brodeur, G. M., Ikegaki, N. (1999). High-Level Expression of EPHB6, EFNB2, and EFNB3 Is Associated with Low Tumor Stage and High TrkA Expression in Human Neuroblastomas. Clin. Cancer Res. 5: 1491-1496 [Abstract] [Full Text]  
• McGregor, L. M., McCune, B. K., Graff, J. R., McDowell, P. R., Romans, K. E., Yancopoulos, G. D., Ball, D. W., Baylin, S. B., Nelkin, B. D. (1999). Roles of trk family neurotrophin receptors in medullary thyroid carcinoma development and progression. Proc. Natl. Acad. Sci. USA 96: 4540-4545 [Abstract] [Full Text]  
• Hiyama, E., Hiyama, K., Yokoyama, T., Fukuba, I., Yamaoka, H., Shay, J. W., Matsuura, Y. (1999). Rapid Detection of MYCN Gene Amplification and Telomerase Expression in Neuroblastoma. Clin. Cancer Res. 5: 601-609 [Abstract] [Full Text]  
• Ross, J. A., Davies, S. M. (1999). Screening for Neuroblastoma: Progress and Pitfalls. Cancer Epidemiol. Biomarkers Prev. 8: 189-194 [Full Text]  
• Beglova, N., LeSauteur, L., Ekiel, I., Saragovi, H. U., Gehring, K. (1998). Solution Structure and Internal Motion of a Bioactive Peptide Derived from Nerve Growth Factor. J. Biol. Chem. 273: 23652-23658 [Abstract] [Full Text]  
• Missale, C., Codignola, A., Sigala, S., Finardi, A., Paez-Pereda, M., Sher, E., Spano, P. (1998). Nerve growth factor abrogates the tumorigenicity of human small cell lung cancer cell lines. Proc. Natl. Acad. Sci. USA 95: 5366-5371 [Abstract] [Full Text]  
• Chang, B. B., Persengiev, S. P., de Diego, J. G., Sacristan, M. P., Zanca, D. M., Kilpatrick, D. L. (1998). Proximal Promoter Sequences Mediate Cell-specific and Elevated Expression of the Favorable Prognosis Marker TrkA in Human Neuroblastoma Cells. J. Biol. Chem. 273: 39-44 [Abstract] [Full Text]  
• Poluha, W., Schonhoff, C. M., Harrington, K. S., Lachyankar, M. B., Crosbie, N. E., Bulseco, D. A., Ross, A. H. (1997). A Novel, Nerve Growth Factor-activated Pathway Involving Nitric Oxide, p53, and p21WAF1 Regulates Neuronal Differentiation of PC12 Cells. J. Biol. Chem. 272: 24002-24007 [Abstract] [Full Text]  
• Gaetano, C., Matsuo, T., Thiele, C. J. (1997). Identification and Characterization of a Retinoic Acid-regulated Human Homologue of the unc-33-like Phosphoprotein Gene (hUlip) from Neuroblastoma Cells. J. Biol. Chem. 272: 12195-12201 [Abstract] [Full Text]  
• Muragaki, Y., Chou, T. T., Kaplan, D. R., Trojanowski, J. Q., Lee, V. M.-Y. (1997). Nerve Growth Factor Induces Apoptosis in Human Medulloblastoma Cell Lines that Express TrkA Receptors. J. Neurosci. 17: 530-542 [Abstract] [Full Text]  
• Cortazzo, M. H., Kassis, E. S., Sproul, K. A., Schor, N. F. (1996). Nerve Growth Factor (NGF)-Mediated Protection of Neural Crest Cells from Antimitotic Agent-Induced Apoptosis: The Role of the Low-Affinity NGF Receptor. J. Neurosci. 16: 3895-3899 [Abstract] [Full Text]  
• Brodeur, G. M. (1996). Schwann Cells as Antineuroblastoma Agents. NEJM 334: 1537-1539 [Full Text]  
• Norris, M. D., Bordow, S. B., Marshall, G. M., Haber, P. S., Cohn, S. L., Haber, M. (1996). Expression of the Gene for Multidrug-Resistance-Associated Protein and Outcome in Patients with Neuroblastoma. NEJM 334: 231-238 [Abstract] [Full Text]  
• Kovacina, K. S., Roth, R. A. (1995). Characterization of the Endogenous Insulin Receptor-related Receptor in Neuroblastomas. J. Biol. Chem. 270: 1881-1887 [Abstract] [Full Text]  
• Chou, T. T., Trojanowski, J. Q., Lee, V. M.-Y. (2001). p38 Mitogen-activated Protein Kinase-independent Induction of gadd45 Expression in Nerve Growth Factor-induced Apoptosis in Medulloblastomas. J. Biol. Chem. 276: 41120-41127 [Abstract] [Full Text]  
• Manohar, C. F., Short, M. L., Nguyen, A., Nguyen, N. N., Chagnovich, D., Yang, Q., Cohn, S. L. (2002). HuD, a Neuronal-specific RNA-binding Protein, Increases the in Vivo Stability of MYCN RNA. J. Biol. Chem. 277: 1967-1973 [Abstract] [Full Text]  
• Tang, X. X., Zhao, H., Robinson, M. E., Cohen, B., Cnaan, A., London, W., Cohn, S. L., Cheung, N.-K. V., Brodeur, G. M., Evans, A. E., Ikegaki, N. (2000). Implications of EPHB6, EFNB2, and EFNB3 expressions in human neuroblastoma. Proc. Natl. Acad. Sci. USA 97: 10936-10941 [Abstract] [Full Text]